Spays And Neuters Global Market Intelligence Report 2026: Forecast To Reach $3.54 Billion By 2031 As Pet Ownership And Animal Welfare Initiatives Expand
Dublin, Sept. 03, 2026 (GLOBE NEWSWIRE) -- The "Spay and Neuter - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
The global spay and neuter market is estimated to reach USD 2.83 billion in 2026, up from USD 2.70 billion in 2025. The market is projected to grow at a compound annual growth rate of 4.63% between 2026 and 2031, reaching approximately USD 3.54 billion by the end of the forecast period. Growth is being supported by rising companion animal ownership, increased veterinary healthcare spending, government-backed sterilization campaigns, and wider access to advanced veterinary procedures.
Pet Humanization Drives Demand for Veterinary Sterilization Services
Changing household structures and the growing humanization of pets are transforming spay and neuter procedures into routine components of companion animal healthcare. Younger urban households are increasingly adopting pets, while higher disposable incomes are encouraging owners to invest in preventive care and advanced surgical options.
Demand is also rising for laparoscopic procedures, laser-assisted surgery, and longer-acting pain management solutions. These services can improve clinical outcomes while increasing average procedure values for veterinary hospitals and clinics. Expanding pet populations in major emerging markets are further contributing to demand. India's dog population has grown substantially over the past decade, while veterinary care represents a significant share of China's expanding pet economy.
Government and NGO Programs Support Procedure Volumes
Subsidized spay and neuter campaigns remain important market growth drivers, especially in communities where affordability limits access to veterinary care. Municipal voucher programs, no-cost clinic days, animal shelter initiatives, and mobile surgical units are helping increase sterilization rates among owned and stray animal populations.
Best Friends Animal Society's #SpayTogether initiative has deployed more than USD 2 million in funding to support tens of thousands of procedures across multiple U.S. states. The organization also directly completed 20,673 spay and neuter procedures in 2024. Programs of this scale generate consistent patient volumes and encourage veterinary providers to invest in additional surgical capacity, staffing, equipment, and community outreach.
Mandatory municipal sterilization ordinances and broader animal welfare policies are also supporting demand. At the same time, cultural and religious concerns regarding sterilization may restrict adoption in selected markets.
Veterinary Workforce Shortages Remain a Key Challenge
A shortage of qualified veterinary surgeons, particularly in rural and underserved communities, continues to limit market expansion. Shelter surveys indicate that 73% of facilities have delayed procedures because of veterinarian shortages, with 18,648 animals reported on waiting lists in 2024.
Many veterinary graduates favor urban employment, contributing to limited service availability and longer travel distances in rural regions. These barriers can reduce appointment completion rates and delay medically recommended procedures. Europe also faces significant rural coverage gaps, prompting animal welfare organizations to use mobile veterinary teams, community programs, and professional tele-mentoring to maintain access.
Surgical Procedures Continue to Lead the Market
Spay surgeries accounted for 56.08% of market revenue in 2025, supported by higher procedure prices and longer operating-room requirements. Neuter procedures generate substantial case volumes but generally produce lower revenue per procedure, allowing high-throughput veterinary clinics to balance accessibility with operational efficiency.
Non-surgical sterilization represents a smaller but rapidly developing segment. Reversible fertility-control implants and emerging immunocontraceptive vaccines may appeal to pet owners concerned about anesthesia or permanent surgery. As these alternatives gain regulatory and commercial traction, veterinary providers may expand their service offerings. Nevertheless, surgical sterilization is expected to remain central to the global spay and neuter market through 2031.
North America Leads While Asia-Pacific Records the Fastest Growth
North America held 41.74% of global market revenue in 2025, supported by established veterinary networks, animal shelter sterilization requirements, financing options, and public-private voucher programs. Large clinic networks have also helped standardize surgical protocols and postoperative pain management, encouraging adoption of premium veterinary services.
Asia-Pacific is forecast to record the fastest regional growth, with a 7.86% CAGR. Rising middle-class pet ownership, investments in veterinary infrastructure, and government efforts to manage stray animal populations are strengthening demand across China, India, and other regional markets. Although veterinary education capacity is expanding, clinician supply continues to trail demand in several countries.
Europe maintains mature adoption levels under established animal welfare legislation. Germany's shelter sterilization requirements and Spain's integrated animal health initiatives support stable procedure volumes. Latin America, the Middle East, and Africa present additional opportunities, particularly in major urban centers, although rural access, veterinary workforce shortages, affordability constraints, and cultural attitudes continue to affect market development.
Key Topics Covered
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising companion animal ownership & pet-humanization
4.2.2 Government & NGO subsidized spay-neuter campaigns
4.2.3 Mandatory municipal sterilization ordinances
4.2.4 Rising veterinary healthcare expenditure
4.2.5 Breakthrough non-surgical sterilant pipelines
4.2.6 Corporate chain bundled low-cost surgery packages
4.3 Market Restraints
4.3.1 Shortage of skilled veterinary surgeons (rural)
4.3.2 Cultural & religious opposition to sterilization
4.3.3 Post-operative complication concerns among owners
4.3.4 COVID-19 backlog delaying elective procedures
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Bargaining Power of Buyers
4.7.2 Bargaining Power of Suppliers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Procedure Type
5.1.1 Spay (Ovariohysterectomy)
5.1.2 Neuter (Orchiectomy)
5.1.3 Non-surgical Sterilization
5.2 By Animal Type
5.2.1 Dogs
5.2.2 Cats
5.2.3 Other Companion Animals
5.3 By End User
5.3.1 Veterinary Hospitals
5.3.2 Veterinary Clinics
5.3.3 Animal Shelters & NGOs
5.3.4 Mobile / Community Programs
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 South America
5.4.2.1 Brazil
5.4.2.2 Argentina
5.4.2.3 Rest of South America
5.4.3 Europe
5.4.3.1 Germany
5.4.3.2 United Kingdom
5.4.3.3 France
5.4.3.4 Italy
5.4.3.5 Spain
5.4.3.6 Russia
5.4.3.7 Rest of Europe
5.4.4 APAC
5.4.4.1 China
5.4.4.2 India
5.4.4.3 Japan
5.4.4.4 South Korea
5.4.4.5 Australia
5.4.4.6 Rest of APAC
5.4.5 Middle East and Africa
5.4.5.1 GCC
5.4.5.2 South Africa
5.4.5.3 Rest of Middle East and Africa
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
6.4.1 Banfield Pet Hospital
6.4.2 VCA Animal Hospitals
6.4.3 BluePearl Specialty & Emergency Pet Hospital
6.4.4 PetVet Care Centers
6.4.5 VetCor
6.4.6 Independent Vets of Australia
6.4.7 Covetrus
6.4.8 Anicura
6.4.9 Pets at Home Vet Group
6.4.10 Thrive Pet Healthcare
6.4.11 Mission Veterinary Partners
6.4.12 IVC Evidensia
6.4.13 CVS Group plc
6.4.14 Linnaeus Group (Mars)
6.4.15 Neogen Corporation
6.4.16 ASPCA Spay/Neuter Alliance
6.4.17 Humane Society Spay/Neuter Clinics
6.4.18 Emancipet
6.4.19 Vetco (Petco)
6.4.20 Independent Vets of Australia
6.4.21 Anicura
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment